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ABSTRACT
NEVILL, A. M., M. BURROWS, R. L. HOLDER, S. BIRD, and D. SIMPSON. Does Lower-Body BMD Develop at the Expense of
Upper-Body BMD in Female Runners? Med. Sci. Sports Exerc., Vol. 35, No. 10, pp. 1733–1739, 2003. Purpose: Evidence suggests
that exercise plays an important role in stimulating site-specific bone mineral density (BMD). However, what is less well understood
is how these benefits dissipate throughout the body. Hence, the purpose of the present study was to compare the levels of, and the
correlation between, BMD recorded at 10 sites in female endurance runners, and to investigate possible determinants responsible for
any inter-site differences observed. Methods: Repeated measures ANOVA was used to compare the BMD between sites and factor
analysis was used to describe the pattern of intersite correlations. Allometric ANCOVA was used to identify the primary determinants
of bone mass and how these varied between sites. Results: The ANOVA and factor analysis identified systematic differences in BMD
between sites, with the greatest BMD being observed in the lower-body sites, in particular the legs. An investigation into the possible
mechanisms responsible for these differences revealed “distances run” (km·wk1) as a positive, and “years of training” as a negative
determinant of bone mass (P  0.001). However, the effect of a number of determinants varied between sites (P  0.05). Specifically,
the ANCOVA identified that running further distances resulted in higher bone mass in the arms and legs. In contrast, training for
additional years appeared to result in lower bone mass in the arms and lumber spine. Calcium intake was also found to be positively
associated with bone mass in the legs but negatively associated at all other sites. Conclusions: A combination of running exercise and
calcium intake would appear to stimulate the bone mass of women endurance runners at lower-body sites but at the expense of bone
mass at upper-body sites. Key Words: BONE MINERAL DENSITY, INTERSITE CORRELATIONS, FACTOR ANALYSIS,
PROPORTIONAL ALLOMETRIC REGRESSION MODEL, ANCOVA
Osteoporosis is a bone disease associated with lowbone mineral density (BMD) that increases the riskof debilitating bone fractures. Therefore, it is im-
portant to find effective intervention strategies for building
bone and for preventing bone loss. The osteogenic stimulus
provided by load-bearing exercise indicates it is an impor-
tant lifestyle factor that could be used for the prevention of
bone loss (23,26). However, the specific role of physical
activity in the maintenance or enhancement of bone mass or
architecture remains elusive despite considerable research
attention, with results inconsistent and inconclusive due to
numerous methodological variations and limitations (30).
Physical activity has been shown to increase BMD in
animals and human females by 0.9% per year in those limbs
exercised (30). Indeed, strains on bone greater than needed
for steady state remodeling will cause a modeling response
that increases bone mass to meet the increasing load re-
quirement (11). Various studies have concentrated on re-
searching the effects of impact loading regimes across dif-
ferent sports on BMD and bone mineral content (BMC), and
have suggested that the higher the impact load, the higher
the BMD and BMC seen (2,8,17,22,24). However, several
studies have demonstrated that extremely high training
loads can have a detrimental effect on bone (6) often via
hormonal mechanisms (10,12), whereas other studies have
failed to demonstrate a relationship between training pat-
terns and osteoporosis (18). These differences could be due
to the fact that a minimum effective strain stimulus of
mechanical loading is required to evoke an increase in the
level of BMD, thus suggesting that high strain rates, dis-
tributed in unusual patterns, and short in duration and of
sufficient frequency should be used to strengthen the bone
(11).
It has also been suggested that this adaptive response to
impact occurs only at the site of loading, indicating the
site-specific nature of the bone remodeling response (1,28).
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However, the majority of studies have only looked at BMD
and BMC at a few bone sites, i.e., lumbar spine, hip, and
radius (9), leaving incomplete the understanding of the
effect of physical activity on bone health at skeletal sites
throughout the body. In a recent study by Jorgensen et al.
(14), it was concluded that there are significant differences
in the classification of osteoporosis and osteopenia depend-
ing on the bone site measured. Moreover, McCarthy et al.
(19) and Platen et al. (24) stated that the heterogeneity of
response in the skeleton means that it is difficult to predict
overall bone loss from measurements at one particular site.
Indeed, Kanis (15) warns of discrepancies and misclassifi-
cations that can occur when diagnosing osteoporosis due to
highly variable coefficients of variation (3) and inadequate
level of correlation between BMD recorded at different
skeletal sites throughout the body.
Given the site-specific nature of the bone remodeling
response together with this evidence of inadequate correla-
tions between skeletal sites, there would appear to be a lack
of understanding of how the benefits of exercise at the
loaded site dissipates to other sites throughout the body.
Hence, the purpose of the present study was to compare the
levels of, and the degree of correlation between, BMD
recorded at 10 skeletal sites throughout the body in a group
of female endurance runners. If significant and systematic
differences in BMD are observed between sites, a propor-
tional allometric regression model, originally proposed by
Nevill et al. (20), will be used to identify the important
determinants of bone mass and whether these determinants
varied between skeletal sites, thus providing possible insight
into the mechanisms for the observed differences in BMD
between sites.
MATERIALS AND METHODS
Research design. The research was cross-sectional in
design, allowing an investigation into the factors associated
with, and differences between, bone mass recorded at 10
skeletal sites throughout the body in a population of female
endurance runners of varying ages, diets, and training
regimes.
Before initiating the study, the purposes and procedures
were explained verbally and in writing to each participant,
highlighting the possible risks and benefits associated with
participation. Informed, written consent was obtained from
all participants before any testing, in accordance with pro-
tocols defined by the local Kent and Canterbury Ethics
Committee, which gave approval for the study.
Participants. Forty-nine female endurance runners
(recreational to elite standard) were invited and agreed to
participate in the study. To be accepted on the study the
participants had to fulfill the following criteria: female,
Caucasian, aged 18–44 yr (to decrease the possibility of
women going through puberty and the menopause), and
currently involved in endurance running. Participants were
recruited from local and regional athletic clubs in the UK.
Participants were asked to complete an osteoporosis risk
factor and health questionnaire, before study commence-
ment, that evaluated their state of health. Participants were
excluded from the study if they reported current or previous
conditions that might interfere with bone metabolism, i.e.,
heart disease, long-term corticosteroid use, smoking, or
alcoholism. Women currently using or who had previously
used oral contraceptives were not excluded from the study.
The participants exercised on average 8 h·wk1 (2–21 h),
at recreational to elite level for an average of 8 yr (1–20 yr).
The mean distance run per week was 32  17 km (8–112
km). In their training diaries, participants recorded com-
ments on the type of training undertaken, which suggested
that the training was predominantly steady runs, with a few
upper- and lower-body weight-training sessions. However,
the qualitative nature of such comments precluded any
quantitative analysis.
Participants completed questionnaires to assess training,
dietary, and menstrual status (amenorrheic  0–3 cycles a
year; oligomenorrheic  4–9 cycles a year; eumenorrheic
 10 cycles a year). The questionnaires collected informa-
tion on the history of menstruation, training and dietary
status, as well as any recent changes (within the last year).
A prospective, 7-d dietary record was also completed, from
which average energy intake (MJ·d1), zinc (mg·d1), mag-
nesium (mg·d1), phosphorous (mg·d1), and calcium
(mg·d1) intake over this period was assessed (Dietmaster,
version 4.0; Swift Computers Ltd., Phoenix, AZ). Refer to
Table 1 for results.
BMD and body composition measurement. Par-
ticipants were weighed (wearing minimal clothing) to the
nearest 0.1 kg (Balance Beam Scale, Seca, Germany) and
stature recorded to the nearest centimeter (stadiometer at-
tached to Balance Beam Scale, Seca). BMC and density was
measured at the lumbar spine (L2–L4), hip (femoral neck,
Wards triangle, and greater trochanter), and across the
whole body (legs, pelvis, thoracic spine, ribs, and arms),
TABLE 1. Personal characteristics and training details of the female endurance
runners (N  49).
Variable Female Endurance Runners
Age (yr) 30.8  5.6
Stature (cm) 165  5.5
Body mass (kg) 57.5  5.7
Body fat (%) 20.6  6.2
Age at onset of training (yr) 23  8
Years training 8.8  6
Distance (kmwk1) 32.3  17
Training per week (h) 8  5
Sessions per week 5  2
Menarcheal age (yr) 14  2
Gynaecological age (yr) 17  6
Cycle frequency per year 11  2
Cycle flow (d) 5  1
OCA (months) 56  54
Eumenorrhoeic (N) 39
Oilgomenorrhoiec (N) 10
Amenorrhoiec (N) 0
Average energy intake (MJd1) 7.1  1.4
Calcium (mgd1) 821  246
Magnesium (mgd1) 254  58
Zinc (mgd1) 7.3  1.7
Phosphorous (mgd1) 1152  249
Values are mean  SD. Gynecological age is years since menarche; cycle flow is
average length of menstrual flow; cycle frequency per year is average menstrual cycles
experienced per year since menarche; OCA is length of oral contraceptive use in
months.
1734 Official Journal of the American College of Sports Medicine http://www.acsm-msse.org
using dual energy x-ray absorptiometry (DEXA) (Hologic,
QDR 4500w, Hologic Inc., Waltham, MA). Body fat per-
centage was also assessed during the whole-body scan. The
standard Hologic protocol for positioning the lumbar spine,
hip, and whole body was utilized. Bone mineral results were
expressed as BMD (g·cm2). All scans were conducted and
analyzed in the osteoporosis unit at the Kent and Canterbury
Hospital. The in vivo precision of DEXA in the laboratory
is 1% for the lumbar spine, hip, and whole body.
Statistical analysis. Differences in BMD between
sites were compared using repeated-measures ANOVA. Bi-
variate correlations were used to assess the interrelation-
ships between BMD recorded at 10 skeletal sites throughout
the female runners’ body. Factor analysis (using principal
component analysis as the method of extraction) with vari-
max rotation was used to determine the minimum number
and nature of the components or factors necessary to de-
scribe these correlations.
In an attempt to explain any differences in bone mass
between sites and in the pattern of correlations, the follow-
ing proportional allometric repeated-measures model
adapted from Nevill et al. (20) was used to describe the
important determinants of BMC (BMCij) at site i (i  1, 2,
. . ., 10) and participant j (j  1, 2, . . ., 49), and how these
might vary across the skeletal sites,
BMCijAijk1massjk2exp(aijbagejcagej2d%fatj)ij, (1)
where for participant j, Aij is the projected bone area of the
skeletal site i being assessed, aij is the constant intercept for
each site, %fatj is the whole-body fat (%), and ij is the
multiplicative error ratio. The model can be linearized with
a log-transformation, and ANCOVA can then be used to
estimate the differences due to “site” having controlled for
differences in participants and other confounding covariates.
The transformed log-linear ANCOVA model becomes,
loge(BMCij)
k1loge(Aij)k2loge(massj)aijbagejcagej2d%fatjloge(ij).
(2)
Further determinants thought to be associated with BMC
can be introduced into the model as additional covariates,
e.g., average energy intake (MJ·d1), calcium (mg·d1)
intake, distance run (km·wk1), and years of training, and
ANCOVA can be used to assess whether any of the deter-
minants varied from site to site, by introducing and testing
the significance of a “covariate-by-site” interaction.
A significance level of 0.05 was accepted for all statistical
procedures. If either the ANOVA or ANCOVA main effect
difference between sites was detected, pairwise comparisons
were made using the Bonferroni adjustment for multiple
comparisons.
RESULTS
The personal characteristics and training details of the
female runners are summarized in Table 1.
The repeated measures ANOVA of BMD identified a
significant main effect due to sites (P  0.001). The mean
differences (SD) in BMD between sites can be seen in
Figure 1. Bonferroni multiple comparison methods identi-
fied the legs as having the greatest BMD that was signifi-
cantly greater than all other sites (P  0.001). Due to the
fact that bone at each site has a different shape, these
comparisons in BMD should be interpreted with some cau-
tion, as explained in the Discussion.
All intersite correlations were significant (P 0.05) with
the exception of those between the left arm and left rib,
thoracic spine and pelvis, denoted by “NS” (see Table 2).
The factor analysis suggested a two-factor solution, i.e.,
the 10 skeletal-site BMD variables were reduced to just two
new underlying variables/factors or components. Using a
convenient cut-off point of 0.55, the factor loadings indi-
cated a complete separation of sites into an upper- (ribs,
right arm, thoracic spine, lumber spine, and pelvis) and
lower-body (legs and hip) component. Together, these two
components explained 71% of the variance with 59% being
associated with the upper-body component. Interestingly,
the left arm failed to identify strongly with either compo-
nent. Note that if a less stringent cut-off point of 0.40 is
used, the hip and thoracic spine sites load moderately on
both components. Some of these patterns can be confirmed
by examining the correlations in Table 2.
The repeated measures ANCOVA of log-transformed
BMC confirmed the significant main effect due to sites.
Note that because there was no difference between adjusted
BMC data for the right- and left-side of either the legs, arms
or ribs, these data were collapsed into three “combined”
BMC sites for the legs, arms, and ribs (see Fig. 1). The
ANCOVA also identified significant determinants (covari-
ates) as loge (Ai), age, age2, distance run (km·wk1) and
years of training. Note that the “site” and “subject” dif-
ferences together with the covariates identified in the
ANCOVA were able to explain R2 99.4% of the variance
in log-transformed BMC.
To assess whether the effect of the covariates varied
across the different sites, each covariate was entered as a
covariate-by-site interaction into the ANCOVA. The deter-
minants age (P  0.025), distance-run (P  0.01), years-
FIGURE 1—Differences in mean BMD (SD) by skeletal sites (P <
0.001).
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of-training (P  0.001), and calcium intake (P  0.032)
were found to have an effect on BMC, which varied signif-
icantly between sites. The fitted slope parameters of the
covariates and their interactions are listed in Tables 3 and 4,
respectively. Note that the analysis estimated the slope
parameters for all four interactions using the hip as the
baseline site, and the deviations in the slopes of the other
sites from the baseline hip are reported in the Table 4. With
the addition of these interactions, the revised ANCOVA
model was now able to explain R2  99.5% of the variance
in log-transformed BMC.
Interestingly, the strongest relationship between
loge(BMCi) and log-transformed projected area, loge(Ai),
appears to be linear (Fig. 2), confirmed by the estimated
areal exponent, k1 being close to unity (see Table 3). This
result is relevant to the method of normalizing BMC for
differences in projected bone area, a finding that will be
addressed later in the Discussion.
DISCUSSION
The ANOVA confirmed that the greatest BMD of the
women endurance runners was in the legs, supporting the
theory that the benefit of exercise is greatest at the loaded
site. Figure 1 also confirmed that the upper-body sites of the
arms, ribs, and, to a lesser extent, the thoracic spine, had the
lowest mean BMD, suggesting that the level of BMD de-
clines in sites the further they are located away from the
loaded site. However, these findings are not entirely con-
clusive because comparing the BMD measurements re-
corded at different skeletal sites that have bones of different
shapes, and in particular different bone depths or thick-
nesses, may result in misleading and incomparable bone
densities. Nevertheless, the level of significance identified
by the ANOVA of BMD provides strong evidence that the
benefits of exercise is greatest at the loaded site and declines
systematically in those sites the further they are located
away from the loaded site.
Further evidence for this theory comes from the inter-site
correlations. For the present population of women endur-
ance runners, the factor analysis was unable to confirm a
single factor (or principal component) necessary to describe
the pattern of correlations. The factor analysis was able to
identify two distinct components or factors that could be
labeled as an upper-body and a lower-body component. The
upper-body component consists of the ribs, right arm, tho-
racic spine, lumber spine and pelvis. The lower-body com-
ponent contained both legs and the hip, with the left arm
failing to identify strongly with either component. Although
the hip did load moderately on the upper-body as well as
strongly with the lower-body component, the factor analysis
provides evidence that different mechanisms may be re-
sponsible for developing upper- and lower-body bone mass
within this population of women endurance runners.
In order to understand what might cause the similarity
within, and differences between, the upper- and lower-body
skeletal sites, a proportional allometric ANCOVA model
proposed by Nevill et al. (20) was used to identify any
differences in BMCi between sites having controlled for the
projected bone area (Ai), body mass, age, whole-body fat
(%), the distance run (km·wk1), and years of training. The
ANOVA did indeed confirm that the legs had the greatest
adjusted BMC that was greater than all other sites with the
exception of the lumber spine and hip. However, as de-
scribed above, these differences are not entirely conclusive
because the bones have different shapes, and in particular,
different depths, that may result in misleading and incom-
parable bone densities. On the other hand, identifying the
important determinants of bone mass among these women
endurance runners and how these determinants vary be-
tween sites is a valid method of identifying the likely mech-
anisms responsible for the observed mean and correlational
differences in BMD between the upper- and lower-body
skeletal sites.
As can be seen in Figure 2, the relationship between
loge(BMCi) and log-transformed projected area, loge(Ai), is
acceptably linear. This was confirmed by the fitted projected
area exponent, k1 being approximately unity (see Table 3).
This supports the use of the traditional BMD ratio BMDi 
BMCi/(Ai) when attempting to normalize BMC for differ-
ences in projected bone area (Ai). Interestingly, this areal
TABLE 3. The estimated slope parameters/coefficients of the covariates from the
log-transformed ANCOVA model (Eq. 2).
Term Coef SEE T P
Constant 0.789 0.267 2.95 0.001
Inarea(k1) 0.930 0.028 32.74 0.001
Age (hip) 0.083 0.018 4.51 0.001
Age2 0.0016 0.0003 4.81 0.001
Distance (hip) 0.0029 0.0007 4.0 0.001
Years-of-training (hip) 0.011 0.002 5.17 0.001
Calcium (hip) 0.00003 0.00005 0.64 0.521
SEE is the standard error of estimate, T is the “t-test” standard score, and P is the
associated probability based on Student’s t distribution.
TABLE 2. Correlations between BMD recorded at 10 skeletal sites in female endurance runners (N  49).
BMD Site
Right
Arm
Left
Rib
Right
Rib
Thoracic
Spine
Lumbar
Spine Pelvis
Left
Leg
Right
Leg Hip
Left arm 0.48 0.20NS 0.29 0.21NS 0.33 0.16NS 0.30 0.38 0.31
Right arm 1 0.53 0.66 0.55 0.70 0.62 0.46 0.49 0.63
Left rib 1 0.88 0.54 0.51 0.67 0.46 0.45 0.45
Right rib 1 0.58 0.64 0.78 0.49 0.50 0.58
Thoracic spine 1 0.67 0.55 0.61 0.59 0.62
Lumbar spine 1 0.72 0.44 0.48 0.69
Pelvis 1 0.39 0.40 0.55
Left leg 1 0.89 0.75
Right leg 1 0.70
All intersite correlations (P  0.05) except those denoted by “NS” (P  0.05).
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BMD ratio has come under strong criticism by various
authors (7,16). These authors argue that if bone mass ac-
quisition increases in proportion to an individual’s skeletal
bone volume, then theoretically the projected bone area, Ap,
will not accurately reflect the skeletal bone volume being
assessed. In an attempt to reduce the possible confounding
effects of bone size, Carter and coworkers (7) recommend
reporting an alternative ratio, referred to as the bone mineral
apparent density (BMAD), estimated by the ratio BMAD 
BMC/(Ap)3/2 (gcm3), where (Ap)3/2 is an estimate of the
skeletal bone volume. Clearly, the results from this and a
previous study using elite male athletes (21), provides com-
pelling evidence that, certainly within such athletic popula-
tions, BMC increases in proportion to the projected bone
area Ap rather than an estimate of the skeletal bone volume
(Ap)3/2, thus supporting the use of the traditional ratio BMD.
The variable age was entered into the ANCOVA model as
a quadratic polynomial (using both the age and age2 terms),
to accommodate the likelihood that bone mass peaks during
mid-adolescence or early adulthood (5,29). As anticipated,
both covariate terms made a significant contribution to the
model for bone mass. Using elementary differential calcu-
lus, the fitted age and age2 parameters allow us to predict
BMC (of the base-line site hip) will peak at the age of
(b)/(2c)  0.083/(2*0.0016)  25.9 yr. However, the
significant age-by-site interaction confirms that bone mass
FIGURE 2—The relationship between log-
transformed BMC (lnBMC), and log-trans-
formed projected area (lnarea), by skeletal
sites.
TABLE 4. The estimated slope parameters/coefficients of the covariate-by-site interactions from the log-transformed ANCOVA model (Eq. 2).
Term Coef SEE T P
Distance-by-site interaction (F6,418  2.86; P  0.010)
Arms 0.00127 0.00038 3.36 0.001
Legs 0.00062 0.00038 1.65 0.100
Lumbar 0.00053 0.00050 1.05 0.295
Pelvis 0.00089 0.00050 1.78 0.075
Ribs 0.00029 0.00038 0.76 0.448
Thoracic 0.00023 0.00050 0.47 0.642
Hip 0a
Years of training-by-site interaction (F6,418  5.13; P  0.001)
Arms 0.00335 0.00107 3.14 0.002
Legs 0.00440 0.00106 4.13 0.001
Lumbar 0.00338 0.00142 2.38 0.018
Pelvis 0.00148 0.00141 1.05 0.296
Ribs 0.00003 0.00107 0.03 0.979
Thoracic 0.00071 0.00141 0.51 0.613
Hip 0a
Age-by-site interaction (F6,418  2.44; P  0.025)
Arms 0.00205 0.00113 1.82 0.070
Legs 0.00017 0.00112 0.15 0.883
Lumbar 0.00097 0.00149 0.65 0.513
Pelvis 0.00220 0.00150 1.47 0.142
Ribs 0.00194 0.00112 1.73 0.084
Thoracic 0.00079 0.00149 0.53 0.597
Hip 0a
Calcium-by-site interaction (F6,418  2.33; P  0.032)
Arms 0.000025 0.000026 0.96 0.336
Legs 0.000065 0.000026 2.47 0.014
Lumbar 0.000044 0.000035 1.26 0.207
Pelvis 0.000030 0.000035 0.86 0.389
Ribs 0.000029 0.000026 1.13 0.261
Thoracic 0.000014 0.000035 0.40 0.692
Hip 0a
SEE is the standard error of estimate, T is the “t-test” standard score, and P is the associated probability based on Student’s t distribution.
a These parameters are set to zero because they are redundant.
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at axial sites (e.g., lumber and thoracic spine) will peak
earlier than more peripheral sites (e.g., arms and ribs) (4,27).
The overall positive association between adjusted BMC
and distance run (kmwk1) might have been anticipated
(the deviations from the positive baseline hip slope coeffi-
cient, reported in Table 4, all remain positive). Women
runners that train by running greater distances are more
likely to stimulate a positive osteogenic effect (25). The
overall negative association between adjusted BMC and
years of training (again the deviations from the negative
baseline hip slope parameter, reported in Table 4, all remain
negative) could simply reflect the lighter training loads of
those dedicated women runners who have been running for
many years, i.e., it is unlikely that women runners can sustain
heavy training load indefinitely. Thus as the years of running
progress, a dose-response relationship would be unlikely to
result in sufficient force for bone remodelling (11).
When we investigated whether any of the above associ-
ations between BMC and those determinants identified in
Table 3 varied across the different sites, the distance run
(km·wk1), years of training, and calcium (mg·d1) intake
were found to vary significantly between sites (P  0.05).
Having identified that running greater distances had an
overall beneficial effect on BMC, the interaction term iden-
tified the BMC of the legs and arms to benefit from running
longer distances compared with the other sites. The surpris-
ing benefit to the arms from running greater distances could
be due to the extra muscle contractions that take place in the
arms when running longer distances, compared with the
shorter distances (23). In addition, those running greater
distances tended to be the competitive athletes who com-
bined mainly upper-body weight training in their regimes.
Unfortunately, because details concerning upper-body
weight training were only recorded in the women’s diaries
as qualitative comments, we were unable to confirm this
effect using the ANCOVA analysis. We must acknowledge
this as a limitation of the study and an area for future
research.
Thus, in addition to the running (13), the weight training
could have provided an effective osteogenic stimulus to the
arms. Furthermore, having identified that bone mass de-
clines with additional years of training at all skeletal sites,
the adjusted BMC of the arms, and to a lesser extent the
lumber spine, appears to decline at a greater rate compared
with the other sites. Note that the rate of decline associated
with additional years of training was least in the legs.
The other important finding of the present study was the
differential effect of calcium intake on bone mass across the
various skeletal sites, identified by the significant calcium-
by-site interaction (P  0.032). Inspection of Tables 3 and
4 is able to confirm that there appears to be no benefit of
calcium intake at the baseline site (hip). However, the cal-
cium-by-site interaction revealed a positive association be-
tween calcium intake and BMC at the legs (P  0.014) but
a negative association at all other sites. This suggests that
calcium intake is being diverted to the legs at the expense of
all other skeletal sites. Note that none of the remaining
dietary and menstrual-status covariates (average energy in-
take, zinc, magnesium, phosphorous, and menstrual cycles
per year) nor the covariate-by-site interactions made a sig-
nificant additional contribution to the ANCOVA analysis of
log-transformed BMC.
In conclusion, these findings support previous research
that suggests endurance running has a positive osteogenic
effect on bone in lower-body skeletal sites and also supports
the theory that bone mass acquisition obeys a principle of
specificity (1). The present results also support the notion
that although running longer distances are likely to stimu-
late bone mass, running for many years may be associated
with lower levels in bone mass especially at upper-body
sites. A possible mechanism for this result was identified
when calcium intake was found to be positively associated
with greater leg BMC but negatively associated with all
other sites. Hence, although endurance running had a pos-
itive benefit to bone mass at the lower-body sites especially
the legs, these benefits would appear to be at the expense of
bone mass acquisition at some upper-body sites, where
lower levels in bone mass were observed in dedicated
women runners who trained for many years.
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